The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 17, 2025 | Spencer John N JR | Director | Buy(P) | 10K | $0.55 | $6K |
| Aug 7, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 1K | $0.67 | $742 |
| Jun 5, 2025 | Dodd David A | President, CEO, Director | Grant(A) | 186K | — | $0 |
| Jun 5, 2025 | Reynolds Mark | CFO | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Sharkey John W. | VP, Business Development | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Newman Mark J | Chief Scientific Officer | Grant(A) | 70K | — | $0 |
| Jun 5, 2025 | Spencer John N JR | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Morgan Jayne | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | McNally Robert T | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Kollintzas Dean G | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Chase Randal D | Director | Grant(A) | 10K | — | $0 |
| Jun 5, 2025 | Lemerond Nicole | Director | Grant(A) | 10K | — | $0 |
| Apr 10, 2025 | Sharkey John W. | VP, Business Development | Buy(P) | 6K | $0.99 | $6K |
| Apr 10, 2025 | Spencer John N JR | Director | Buy(P) | 10K | $0.98 | $10K |
| Apr 1, 2025 | Dodd David A | President, CEO, Director | Buy(P) | 10K | $1.08 | $11K |
| Mar 31, 2025 | Reynolds Mark | CFO | Buy(P) | 7K | $1.08 | $7K |
| Aug 12, 2024 | Spencer John N JR | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Morgan Jayne | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | McNally Robert T | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Lemerond Nicole | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Kollintzas Dean G | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Chase Randal D | Director | Grant(A) | 8K | — | $0 |
| Aug 12, 2024 | Sharkey John W. | VP, Business Development | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Reynolds Mark | CFO | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Newman Mark J | Chief Scientific Officer | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 16K | — | $0 |
| Aug 12, 2024 | Dodd David A | President, CEO, Director | Grant(A) | 35K | — | $0 |
| Aug 9, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 8K | $1.95 | $16K |
| Feb 22, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 8K | $2.27 | $19K |
| Feb 21, 2024 | Dodd David A | President, CEO, Director | Buy(P) | 520 | $2.15 | $1K |
| Feb 7, 2024 | Reynolds Mark | CFO | Buy(P) | 2K | $2.77 | $6K |
| Dec 22, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 7K | $0.36 | $2K |
| Sep 25, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy(P) | 10K | $0.52 | $5K |
| Aug 25, 2023 | Dodd David A | President, CEO, Director | Buy(P) | 35K | $0.57 | $20K |
| Aug 18, 2023 | Reynolds Mark | CFO | Buy(P) | 10K | $0.52 | $5K |
| Aug 1, 2023 | Reynolds Mark | CFO | Grant(A) | 100K | — | $0 |
| Aug 1, 2023 | Dodd David A | President, CEO, Director | Grant(A) | 250K | — | $0 |
| Aug 1, 2023 | Newman Mark J | Chief Scientific Officer | Grant(A) | 100K | — | $0 |
| Aug 1, 2023 | Sharkey John W. | VP, Business Development | Grant(A) | 100K | — | $0 |
| Aug 1, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Grant(A) | 15K | — | $0 |
| Aug 1, 2023 | Chase Randal D | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Kollintzas Dean G | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Lemerond Nicole | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | McNally Robert T | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Morgan Jayne | Director | Grant(A) | 50K | — | $0 |
| Aug 1, 2023 | Spencer John N JR | Director | Grant(A) | 50K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).